Search Results - Chang KM,

Experience in Using Hypercvad Combined with Alemtuzumab in Treating Peripheral T-Cell and T/NK-Cell Neoplasms by Kuan, J.W., Lau, N.S., Chang, K.M., Tan, S.M., Ong, T.C., Purushothamany, V.

Get full text
Get full text

Apparent factor IX inhibitor. by Jameela, S, Rozika, P, Rizalman, J, Phan, CL, Visalachy, P, Chang, KM

Get full text
Get full text
Get full text

Concomitant t(8;21) and trisomy 4 in a patient with Acute Myeloid Leukemia (AML) by Phan CL, Ong TC, Chang KM, Zubaidah Z, Puteri Jamilatul NMB

Get full text
Get full text
Get full text

Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population by Sujatha, S., Gan, G.G., Zain, S.M., Haerian, B.S., Bee, P.C., Lian, L.H., Chang, K.M., Ong, T.C., Mohamed, Z.

Get full text
Get full text

Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study by Tan, B.K., Tan, S.B., Chen, L.C., Chang, K.M., Chua, S.S., Balashanker, S., Kamarul Jaman, H.N.B., Edmund, S.C., Bee, P.C.

Get full text
Get full text
Get full text

Vancomycin resistant Enterococcus (VRE): Prevalence and characteristics in a tertiary hospital in Malaysia by Mohamed N.A., Hussin H., Chang K.M., Hashim R., Ahmad N.